Brain metastases are one of the most severe complications of melanoma, the most aggressive type of skin cancer. Researchers ...

A new Phase I clinical trial from London Health Sciences Centre Research Institute (LHSCRI) has found high-precision ...

Patients with BRAF V600E-mutant metastatic colorectal cancer experienced poor clinical outcomes with systemic therapy, ...

Nelmastobart (hSTC810) combined with capecitabine therapy in metastatic colorectal cancer with resistance or intolerance to oxaliplatin and irinotecan-based chemotherapy: A phase 1b clinical trial.

Risk of peritoneal recurrence following laparoscopic versus open surgery for stage II or III colorectal cancer (JCOG2310A): An integrated analysis of three phase III randomized controlled trials. This ...

According to GlobalData, Phase II drugs for Peritoneal Cancer have a 37% phase transition ... who have received at least two prior therapies for metastatic disease. Trodelvy is indicated for the ...

Oligometastases, defined as only a single or a few "spots" of metastatic disease, may be treated with radiation. These techniques can improve outcomes for a select subset of patients, such as those ...

“Despite considerable progress in the HR positive, HER2 negative metastatic breast cancer treatment landscape, new therapies are still needed to tackle the frequent and complex challenge of disease ...

HER2-negative breast cancer who have received prior endocrine-based therapy and chemotherapy for unresectable or metastatic disease. TROPION-Breast01 is a global, randomised, multicentre ...

Verzenio is indicated in combination with fulvestrant for the treatment of women with hormone receptor positive and HER2 negative advanced or metastatic breast cancer with disease progression ...